Medical

20 stories about Medical
מריחואנה קנאביס גראס 2

Cannabis Company Therapix Biosciences to Raise $2.25 Million in Direct Offering

28.03.19|Lilach Baumer
In December, Israel-based Therapix scrapped a deal to be acquired by Canadian FSD Pharma for $48 million worth of FSD stock
נאסדק

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed Bioblast, Raises $5.3 Million

28.03.19|Lilach Baumer
The merged entity listed on Nasdaq under the ticker “ENLV”
מטה טבע פתח תקווה

Teva Settles Patent Litigation Case for Blood Sugar Stabilizer With Novo Nordisk

24.03.19|CTech
Under the settlement agreement, Teva will be able to sell a generic version of the drug as of 2023
תרופה תרופות סל התרופות

Israel Hopping on the Opiate Regulation Wagon

17.03.19|Adrian Filut
The Israeli health ministry is setting up a task force to examine current regulation, with the intention of halting the increasingly frequent prescription of opiates in the country
מריחואנה קנאביס גראס 2

Cannabis Company InterCure Sells Part of Regenera Pharma Stake

11.03.19|Tzally Greenberg
InterCure will sell 1.35% of Regenera for a profit of almost $1 million, leaving it with a 12.27% stake
נאסדק

Tower Semiconductor Announces Medical Chip Development With Chinese Biotech Company Axbio

06.03.19|Hezi Sternlicht
Tower stated the device, which is intended for blood test analyses, is planned to go into production in mid-2019
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million

06.03.19|Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
איתמר מדיקל WatchPAT

Itamar Medical Starts Trading ADS on Nasdaq

27.02.19|Lilach Baumer
The Tel Aviv-listed medical diagnosis company received SEC approval for listing its ADS on the American exchange
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Micro Endoscope Developer Zsquare Raises $10 Million

27.02.19|Lilach Baumer
The Israel-headquartered company intends to use the funding to apply for FDA approval
סרטן שד גידול הקפאה אייסקיור

Cancer Freezing Company IceCure Raises Just Third of Planned Offering

21.02.19|Tzally Greenberg
IceCure develops an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor, freezing its tissue
רופא רפואה טכנולוגיה ממוחשבת

Genetic Interpretation Startup Emedgene Raises $6 Million

20.02.19|Lilach Baumer
Emedgene develops a technology that automates the analysis and interpretation of genetic information at scale
default image

Cannabis Outfit Recruits Israeli Nobel Laureate for Board

17.02.19|Tzally Greenberg
Cannabis-based pharma company Panaxia, which is set to merge with Tel Aviv-listed shelf company Herodium, announced Israeli biologist Aaron Ciechanover will join its board
בוט רפואה מיקרוסופט בינה מלאכותית

Microsoft Launches Medical AI Service

11.02.19|Adi Pick
The service, intended to enable healthcare organizations to build and deploy AI-powered virtual assistants and chatbots, was spearheaded by a team from the company's Israeli research and development center
מפעל טבע קריית שמונה

Teva to Sell Northern Israeli Facility to Private Equity Fund FIMI

06.02.19|Tzally Greenberg
Teva unveiled a reorganization plan in December 2017 to ameliorate its debilitating debt, announcing its intention to close or sale facilities and layoff 25% of employees by 2019
השם סילנטיס sealantis

Algae-Based Medical Adhesives Developer Sealantis Sold for $25 Million

31.01.19|Lilach Baumer
Sealantis uses an algae-based polymer that does not contain proteins, reducing risks of infection or allergic reaction
בריאות דיגיטלית מדעי החיים רפואה טיפול 2

Healthcare Cybersecurity Startup Medigate Raises $15 Million

29.01.19|Meir Orbach
Medigate's technology protects medical devices from cyber attacks once connected to a healthcare provider network
מריחואנה קנאביס גראס 1

In Tel Aviv, Reform Sends Cannabis Stocks Down as Shareholders Sell High

28.01.19|Lilach Baumer
On Sunday, the Israeli government gave the final stamp of approval to a cannabis export reform. In response, Tel Aviv’s cannabis stocks tumbled
נאסדק

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

24.01.19|Lilach Baumer
Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering
וינסנט צ'נגוויז Vincent Tchenguiz

New Israeli Medical Technologies Fund Aims to Close $150 Million in Commitments by End of Year

21.01.19|Tzally Greenberg
CBG Asset Management, an investment firm owned by U.K.-based businessman Vincent Tchenguiz, is one of the partners in the venture
תרופה תרופות סל התרופות

Struggling InSight Biopharmaceuticals Acquired by Hong Kong’s Gencor Pacific

13.01.19|Meir Orbach
In 2017, following financial collapse, the intellectual property and assets of Israel-based InSight were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner